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The attitudes and experiences of pathologists and coroners to the provision of biochemical forensic toxicology in
the Republic of Ireland were determined using separate questionnaires to each group anonymously. Replies were
received from 36/88 (41%) of pathologists and 19/71 (27%) of coroners. 37% of coroners considered that
histopathologists give an adequate opinion in forensic toxicology yet 58% of pathologists reported that they did
not have adequate access to expert medical interpretative toxicological opinion. For drug-drug interactions and
metabolic diseases, 69% of pathologists were unhappy with the processes and 68% of coroner replies did not know
if vitreous samples were used appropriately. There is a clear requirement for retraining of coroners and for the
appointment of medical toxicology expertise to improve the quality of service for coroners.
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The rationale for developing a National Institute for
Forensic Toxicology in Ireland was published (Tormey
2013). It served as a critique of the toxicology service
for coroners in Ireland and outlined detailed recommen-
dations for corrective actions. Because the paper was pub-
lished by Open Access, it was widely read by government
officials and pathologists involved in the coronial service.
By June 22 2014, there were 878 total accesses listed in
the article metrics by Springer. Despite this and an accept-
ance of the validity of the professional governance issues
raised, there has been inertia with regard to change
management. The State Laboratory in Kildare is used
for coronial toxicology and has widened its analytical
service but has no formal arrangement with a hospital
laboratory for routine biological analytes including,
glucose, urea, creatinine, lactates, ketones, insulin and
proinsulin. Laboratory reports for pathologists have no
medically qualified toxicology input and interpretation
is offered by an analytical scientist usually by quoting
Baselt’s Textbook (Baselt 2011). This is an unsatisfactory* Correspondence: billtormey@gmail.com
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in any medium, provided the original work is pgovernance structure which must be reformed. The State
Laboratory accreditation is ISO/IEC 17025. 2005 2nd
Edition and these are the general requirements for testing
and calibration laboratories. By contrast, medical laborator-
ies are assessed against ISO 15189 standard in developing
their quality standard systems. Beaumont Hospital was
formerly associated with the coroners’ service and was
accredited by Clinical Pathology Accreditation (UK).
Therefore there is a reporting hiatus for medical cases
at the State Laboratory which is ignored.
Service user satisfaction is a conventional measure. There
is no published information in Ireland on the requirements
and attitudes of pathologists performing autopsies and the
coroners receiving reports. Thus appropriate questionnaires
were designed to consult each group and fill the informa-
tion gap to facilitate change management (Boynton 2004).Methods and results
A separate six item questionnaire was sent to all prac-
ticing 88 histopathologists and 4 forensic pathologists
listed in the Irish Medical Directory for 2013 (Irish
Medical Directory 2013). A different six item survey
was sent to all 72 coroners and deputy coroners listed
on the Irish coroners service website (www.coroners.ie/en/
CS/Pages/Coroner%20Contact%20Details). An explanatoryan Open Access article distributed under the terms of the Creative Commons
g/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
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there was no identifying mark on the paper questionnaire
to preserve anonymity.
Pathologists
The text of the explanatory letter to pathologists read:-
“In coroner’s cases, the final interpretative report for
the court is collated by the dissecting pathologist. The
purpose of the survey is to garner the opinions of
pathologists who collate the final autopsy report for
the coroner’s courts on forensic biochemistry services
supplied at present. Please circle the relevant Yes/No/
Don’t Know at the end of each query.”
The six questions with the replies to each question are
listed. Despite none being requested, there were a small
number of narrative comments linked to specific ques-
tions written on the returned questionnaires.
1. Do you have access to expert medical opinions on
forensic toxicology values on drugs and metabolism
when you collate your report for the coroner?
Yes 11 (30.6%). No 21 (58.3%). Don’t Know 4 (11.1%).
Narrative comments:
(a) “Interpretation as per State Laboratory report”
(b)“Other than what is on the State Laboratory
report”
(c) “State Lab detailed report”
(d)“Not readily available at present.”
(e) “Senior chemists in State Laboratory used.”
2. Would you prefer a multidisciplinary group meeting
(MDM) of histopathologists, chemical pathologists
and toxicologists to be available to issue, formal
advice to the dissecting pathologist and therefore the
coroner? Forensic toxicology cases would then be
treated in the same way as complex hospital cases.
Yes 20 (55.5%). No 10 (28%). Don’t Know 6 (17%).
Narrative comment:
(a) “Just chemical pathologist and/or toxicologist”
(b)“So far not required. Have attended many
inquests and never a need to call a chemical
pathologist or toxicologist so far”
3. Do you think that drug/drug interactions and
metabolic diseases such as diabetes/ketosis are
adequately processed at present?
Yes 2 (5.5%). No 25 (69%). Don’t Know 9 (25%).
Narrative comment:
(a) “Would value help interpreting”
4. Do you think a National Institute for Forensic
Toxicology should be set up to facilitate
improvement of standards in the coronial system in
medical toxicology cases?
Yes 23 (64%). No 3 (8%). Don’t Know 10 (28%).Narrative comment:
(a) “If you can find funding under current resource
restraint”
(b)“Sufficient number of cases to warrant resource?”
(c) “Not relevant – the vast majority of my cases are
exclusively perinatal.”
5. Would you like to have easy access to an MDM
group for some of your coroner’s cases?
Yes 29 (80%). No 7 (19%). Don’t Know 0.
Narrative comment:
(a) “Just chemical pathologist and/or toxicologist”
6. Ideally, should a National Institute for Forensic
Toxicology cover the whole island of Ireland and
both jurisdictions?
Yes 16 (44%). No 5 (14%). Don’t Know 15 (42%).
Narrative comment:
(a) “Perhaps might allow economic case”
Contrasting long narratives from two pathologists
There were two long narrative replies additional to those
above. These show contrary views, insights and expecta-
tions of the roles of laboratory scientists in contrast to
medical consultant chemical toxicology expertise.
“The State Laboratory service provides us with an
excellent service including detailed reports and
references to support us in our interpretation of values
drug levels etc. In seven years experience as a
consultant performing 80 to 90 autopsies annually I
have not required advice other than that provided by
the State Laboratory. They are available to discuss
results by telephone, add extra tests if additional levels
are requiredand are generally extremely helpful. I
have had several cases of diabetic ketoacidosis and
they have managed to outsource testing for me for beta
hydroxybutyrate etc. I do not have a requirement for
additional support as long as the current service
remains in place. However I realise that the day may
come where an unusual query will arise but hopefully
the State Laboratory will be able to advise. I am
concerned re the new “legal highs” and whether the
State Laboratory is testing for them currently. There
are so many compounds in the UK market that it is
only a matter of time before we see deaths here as a
consequence but I hope the State Laboratory is up to
speed on this. I intend to ask them the next time I am
talking to them.”
By contrast another pathologist wrote: “While I would
like access to toxicology expertise, this should be
through the coroners office and not an MDT setting- ie
equivalent to a toxicology consult. I think that this
would be rarely required and only deal with the
Republic of Ireland jurisdiction”.
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The explanatory letter to coroners and deputy coroners
read:-
“Services for coroners should be reviewed and updated
regularly. The Department of Justice and Equality is
likely to present a Coroner’s Bill to the Oireachtas
soon. I have a specific interest in forensic toxicology.
This summer, a protocol for the introduction of a
National Institute for Forensic Toxicology was
published (copy enclosed). It is important to establish
overall opinions of coroners regarding what they would
prefer in the area of biochemical toxicology. Please
circle the relevant answer Yes/No/Don’t Know at the
end of each query.”
The six questions were:-
1. Do you want a specialist medically qualified group to
be available to provide an expert interpretative
services for the coroner’s service?
Yes 14 (74%). No 3 (16%). Don’t Know 2 (10%)
2. Is the present service satisfactory?
Yes 7 (37%). No 7 (37%). Don’t Know 5 (26%)
Narrative comment:
(a) “As far as my requirements go”
3. Do you consider the advice on potential drug-drug
interactions to be satisfactory at present?
Yes 7 (37%). No 7 (37%). Don’t Know 5 (26%).
4. Do you consider the current use of vitreous samples
for diagnosis of metabolic disorders such as diabetes,
ketosis, electrolytes etc to be appropriate?
Yes 5 (26%). No 1 (5%). Don’t Know 13 (68%).
5. Do you have expert advice available to you on
medical toxicology at present?
Yes 6 (31%). No 10 (53%). Don’t Know 3 (16%).
Narrative comment:
(a) “As incorporated in the toxicology report”
(b)“Whenever this is necessary pathologists will
procure same.”
6. Do you consider the opinions of specialist
histopathologists adequate in forensic biochemistry
and toxicology cases?
Yes 7 (37%). No 5 (26%). Don’t Know 7 (37%).
Narrative comment:
(a) “Unless I am told they are not fit for purpose”
Overall, completed survey replies were received from
36 pathologists with 4 more declaring that they no longer
performed autopsies giving an adjusted reply rate of 36/88
(41%). There were 19 replies from coroners with another
stating that he was a solicitor and not a doctor so could
not reply. This leaves an effective rate of 19/71 (27%).
Because of the context of the necessity for uniformity ofgovernance in forensic medicine, these low response
rates do not invalidate the data.
Discussion
The volumes of known deaths from medical misadventure
are high. In 1999, there were 108,000 deaths from ad-
verse drug reactions after administration of FDA-approved
drugs in USA (http://www.rightdiagnosis.com/m/medical_
misadventure/deaths.htm). Pharmacogenomics and drug
interactions are increasing recognised and will play a part
in the future in death investigations (Lam et al. 2014). Drug
toxicities are common in western societies and the coronial
system must act as a societal watchdog (Pilgrim et al.
2011). Therefore best practice is important.
The coroner service should be reasonably uniform in its
governance and performance. Pathologists would be ex-
pected to have a relatively uniform experience and opinion
of toxicology services if the provision was fit for purpose.
Increasing specialisation in training programmes in medi-
cine makes it unlikely that histopathologists as a group
would retain expertise in toxicology and metabolic disor-
ders to safely deal with non-standard cases. In parallel,
analytical scientists are unlikely to be sufficiently skilled in
medicine to provide a consultative service especially in the
absence of regular exposure to an institutional multidis-
ciplinary case meeting in the presence of appropriate
medical expertise.
The replies from pathologists to all questions involved
in interpretation, medical and toxicological expertise show
a clear majority dissatisfied with the status quo and in
favour of access to an expert group under the guise of a
multidisciplinary group meeting or a National Institute for
Forensic Toxicology. Some narratives show a lack of
insight into other medical specialities. The method ano-
nymity enhances the validity of the study but limits the
percentage returns because reminders could not be tar-
geted at those who failed to reply.
Support for and against a link with Northern Ireland
was evenly balanced even though it is likely to be the most
efficient way of dealing with a small number of cases likely
to need expert advice.
The answers to the drug interactions and metabolic
diseases questions in both surveys show the inadequacy
of current practices in these areas. Sudden death is a fea-
ture in both diabetes and epilepsy and hypoglycaemia or
electrolytes disorders as precipitating causes are likely to
be missed. Vitreous sampling is not common and it is
likely that many metabolic disorders are missed as a
consequence.
Some of the narrative comments show that knowledge
of the role and expertise of medical toxicologists and
chemical pathologists is lacking. That 37% of coroners
consider that histopathologists give an adequate opinion
in forensic toxicology may have unfortunate consequences.
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equate access to expert medical interpretative toxico-
logical opinion. Thus it is not surprising that there are
reports of cases in Ireland where incorrect outcomes of
inquests has resulted from inadequate pathology reports
due to lack of chemical toxicology clinical expertise
(Tormey 2012a, b).
These results confirm the necessity for appropriate
medical toxicological and pharmacological input into
directing and reporting biochemical toxicology for cor-
oners, supporting the published rationale (Tormey and
Moore 2012).
The responses show that there is a clear need for train-
ing of coroners to understand the differing roles of med-
ical specialists and the provenance of laboratory scientists.
Death certification deserves the same diagnostic standard
as antemortem diagnosis.
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